Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02062710 · ClinicalTrials.gov registry record · Phase 4

Antitussive Effect of a Naturally Flavored Syrup Containing Diphenhydramine, Compared With Dextromethorphan and Placebo

A Phase 4 study, sponsored by Montefiore Medical Center.

Completed
Registry status
Phase 4
Development phase
22
Enrollment target

NCT02062710 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 22 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02062710, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.

COMPLETED
Registry status
Phase 4
Development phase
22 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the antitussive (cough-suppressing) effects of two liquid medications: a combination of diphenhydramine and phenylephrine in a naturally cocoa flavoring, and, dextromethorphan syrup, compared with placebo.

Interventions

  • DRUG diphenhydramine/phenylephrine/cocoa; dextromethorophan; placebo
  • DRUG diphenhydramine/phenylephrine/cocoa; placebo; dextromethorphan
  • DRUG dextromethorphan; diphenhydramine/phenylephrine/cocoa; placebo
  • DRUG dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa
  • DRUG placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2014-01
Est. Completion 2014-06
Phase Phase 4

Sponsor

Montefiore Medical Center

345 total trials

What the Registry Record Tells You About NCT02062710

The ClinicalTrials.gov registry entry for NCT02062710 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which diphenhydramine/phenylephrine/cocoa; dextromethorophan; placebo is the first listed.

NCT02062710 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02062710 about?

NCT02062710 is a clinical study titled "Antitussive Effect of a Naturally Flavored Syrup Containing Diphenhydramine, Compared With Dextromethorphan and Placebo". The purpose of this study is to evaluate the antitussive (cough-suppressing) effects of two liquid medications: a combination of diphenhydramine and phenylephrine in a naturally cocoa flavoring, and, dextromethorphan syrup, compared with placebo.

What is the current status of trial NCT02062710?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2014-01. Estimated completion is 2014-06.

What interventions are being tested in trial NCT02062710?

The interventions under investigation include: diphenhydramine/phenylephrine/cocoa; dextromethorophan; placebo (DRUG), diphenhydramine/phenylephrine/cocoa; placebo; dextromethorphan (DRUG), dextromethorphan; diphenhydramine/phenylephrine/cocoa; placebo (DRUG), dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa (DRUG), placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan (DRUG).

Who is sponsoring clinical trial NCT02062710?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.